Pasithea Therapeutics Corp. (KTTA) is an American biotechnology company focused on the development and commercialization of new treatments for neurological and psychiatric disorders. With an emphasis on innovative approaches to treating depression, anxiety, and other mental health conditions, Pasithea is a leading player in the field of neuroscience research. The company is known for its strong focus on the research and development of new therapeutic solutions that can improve patients' quality of life. Pasithea Therapeutics also collaborates with academic and scientific institutions to accelerate innovation in its field. Pasithea Therapeutics Corp. (KTTA) shares could be suitable for investors looking to invest in biotechnology and healthcare with the potential for breakthrough discoveries in mental health treatment.